132
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Trends in Guillain–Barré syndrome mortality in Spain from 1999 to 2013

, , &
Pages 985-988 | Received 23 Jun 2015, Accepted 01 Sep 2015, Published online: 29 Sep 2015

References

  • Walling AD, Dickson G. Guillain-Barré syndrome. Am Fam Physician 2013;87:191–7.
  • Newswanger DL, Warren CR. Guillain-Barré syndrome. Am Fam Physician 2004;69:2405–10.
  • Rajabally YA, Uncini A. Outcome and its predictors in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 2012;83:711–8.
  • Witsch J, Galldiks N, Bender A, et al. Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation. J Neurol 2013;260:1367–74.
  • Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology 2011;36:123–33.
  • Huang W-C, Lu C-L, Chen SC-C. A 15-year nationwide epidemiological analysis of Guillain-Barré syndrome in Taiwan. Neuroepidemiology 2015;44:249–54.
  • Domínguez-Moreno R, Tolosa-Tort P, Patiño-Tamez A, et al. Mortalidad asociada al diagnóstico de síndrome de Guillain-Barré en adultos ingresados en instituciones del sistema sanitario mexicano. Rev Neurol 2014;58:4–10.
  • Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain–Barré syndrome incidence and mortality rates in US hospitals. Neurology 2008;70: 1608–13.
  • Van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology 2013;80:1650–4.
  • Inokuchi H, Yasunaga H, Nakahara Y, et al. Effect of rehabilitation on mortality of patients with Guillain-Barre Syndrome: a propensity matched analysis using nationwide database. Eur J Phys Rehabil Med 2014;50:439–46.
  • Sedano MJ, Calleja J, Canga E, Berciano J. Guillain-Barré syndrome in Cantabria, Spain. An epidemiological and clinical study. Acta Neurol Scand 1994;89:287–92.
  • Piñol-Ripoll G, Larrodé Pellicer P, Garcés-Redondo M, et al. Características del síndrome de Guillain-Barré en el área III de salud de la Comunidad Autónoma de Aragón. An Med Interna 2008;25:108–12.
  • Aladro-Benito Y, Conde-Sendin MA, Muñoz-Fernández C, et al. Síndrome de Guillain-Barré en el área norte de Gran Canaria e isla de Lanzarote. Rev Neurol 2002;35:705–10.
  • McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain-Barré syndrome worldwide. Neuroepidemiology 2009;32:150–63.
  • Ahmad OB, Boschi-Pinto C, Lopez AD, et al. Age standardization of rates: a new WHO standard. GPE Discussion Paper Series No 31. Geneva: World Health Organization; 2001.
  • Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335–51.
  • Spanish Rare Diseases Registries Research Network-SpainRDR. Available from: http://spainrdr.isciii.es/en [accessed 27 Mar 2015].
  • Cuadrado JI, de Pedro-Cuesta J, Ara JR, et al. Guillain-Barré syndrome in Spain, 1985–1997: epidemiological and public health views. Eur Neurol 2001;46:83–91.
  • Cuadrado JI, de Pedro-Cuesta J, Ara JR, et al. Public health surveillance and incidence of adulthood Guillain-Barré syndrome in Spain, 1998–1999: the view from a sentinel network of neurologists. Neurol Sci 2004;25:57–65.
  • Wong AHY, Umapathi T, Shahrizaila N, et al. The value of comparing mortality of Guillain-Barré syndrome across different regions. J Neurol Sci 2014;344:60–2.
  • Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology 2011;36:123–33.
  • Rajabally YA, Uncini A. Outcome and its predictors in Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 2012;83:711–8.
  • Hughes RAC, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev 2014;9:CD002063.
  • Raphaël JC, Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev 2012;7:CD001798.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.